Title:
ESCHERICHIA COLI ENGINEERING STRAIN FOR FUSION EXPRESSION OF TAU-4R PROTEIN
Document Type and Number:
WIPO Patent Application WO/2023/143043
Kind Code:
A1
Abstract:
Disclosed in the present invention is fusion protein Tau-4R, which can be recombined into Escherichia coli to achieve the fusion expression. It is confirmed by means of experiments that the tau protein prepared by the strain may be used in the treatment research of Alzheimer's disease.
Inventors:
CAI JIONG (CN)
Application Number:
PCT/CN2023/071534
Publication Date:
August 03, 2023
Filing Date:
January 10, 2023
Export Citation:
Assignee:
YUANBEN ZHUHAI HENGQIN BIOTECHNOLOGY CO LTD (CN)
International Classes:
A61K38/17; C07K14/47; A61K39/00; A61P25/28; C07K19/00; C12N5/10; C12N15/12; C12N15/62
Domestic Patent References:
| WO2019084488A1 | 2019-05-02 | |||
| WO2021236809A2 | 2021-11-25 |
Foreign References:
| CN113490505A | 2021-10-08 | |||
| CN104185640A | 2014-12-03 | |||
| CN113430230A | 2021-09-24 |
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: